Page last updated: 2024-08-22

cobaltous chloride and Pituitary Neoplasms

cobaltous chloride has been researched along with Pituitary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, W; Huang, L; Shen, X; Wang, D; Yang, Y; Zhu, X1
Arzt, E; Buchfelder, M; Fuertes, M; Gerez, J; Haedo, M; Losa, M; Renner, U; Shan, B; Stalla, GK; Theodoropoulou, M1

Other Studies

2 other study(ies) available for cobaltous chloride and Pituitary Neoplasms

ArticleYear
Relationship between RSUME and HIF-1α/VEGF-A with invasion of pituitary adenoma.
    Gene, 2017, Mar-01, Volume: 603

    Topics: Adenoma; Adult; Animals; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cobalt; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Middle Aged; Models, Biological; Neoplasm Invasiveness; Pituitary Neoplasms; RNA, Small Interfering; Signal Transduction; Transcription Factors; Vascular Endothelial Growth Factor A

2017
RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells.
    Endocrine-related cancer, 2012, Volume: 19, Issue:1

    Topics: Adenoma; Animals; Cell Line, Tumor; Cobalt; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Neovascularization, Pathologic; Pituitary Neoplasms; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2012